Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
International Journal of Medicinal Mushrooms
IF: 1.211 5-Year IF: 1.394 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Print: 1521-9437
ISSN Online: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i2.60
pages 169-172

Current Research Findings on the Effects of Selected Mushrooms on Cardiovascular Diseases

Christelle Francia
Laboratoire de Botanique, Phytochimie et Mycologie, Universite Montpellier I, Faculte de Pharmacies 5 av. Charles Flahault, 34060 Montpellier Cedex 2, France
Sylvie Rapior
Laboratoire de Botanique, Phytochimie et Mycologie, Faculté de Pharmacie, CEFE UMR 5175 CNRS Université de Montpellier Université Paul-Valéry Montpellier EPHE, Montpellier, France
Regis Courtecuisse
Laboratoire de Botanique et de Mycologie, Faculté des sciences pharmaceutiques et biologiques de Lille, EA2692, IFR114, Lille, France
Yves Siroux
Departement de Botanique, Universite Lille II, Faculte des Sciences Pharmaceutiques et Biologiques, 3, rue du Pr. Laguesse, F- 59006 Lille Cedex, France


For about 50 years, scientists have studied the biological activities of Macromycetes on different pathologies. In this article different fungal activities that reduce the effects of risk factors for cardiovascular diseases are reviewed. Among the 17 species tested on animals, 16 demonstrated at least one of the following activities: ability to reduce hypercholesterolemia or to cure dyslipoproteinemia, possibility to decrease arterial hypertension or hyperglycemia, and ability to cure disturbances in platelet aggregation.